Last reviewed · How we verify
NCT05027113
App-Based Mindfulness Meditation for People of Color Who Experience Race-Related Stress
NA trial testing Mindfulness meditation in Stress, Psychological in 155 participants. Completed in 2 December 2022.
2 December 2022
Quick facts
| Lead sponsor | University of California, Los Angeles |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 155 |
| Start date | 13 October 2021 |
| Primary completion | 2 December 2022 |
| Estimated completion | 2 December 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Mindfulness meditation
Conditions studied
- Stress, Psychological — all drugs for Stress, Psychological →
- Anxiety — all drugs for Anxiety →
- Depression — all drugs for Depression →
- Rumination — all drugs for Rumination →
Sponsor
University of California, Los Angeles
Who can join
18 and older, any sex, with Stress, Psychological or Anxiety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In the United States, people of color (POC) are disproportionally affected by stressors related to race/ethnicity compared with their non-Latinx White (NLW). Considering POC exposed to race-related stress are at high risk of developing a mental health disorder, there is a clear need for treatments that allow individuals to cope effectively with these stressors. Among many evidence-based treatments available, mindfulness-based interventions (MBIs) may be particularly well suited to help POC cope. MBIs are hypothesized to be effective via increases in mindfulness and self-compassion, as well as reductions in experiential avoidance, rumination, and emotion suppression. Despite their effectiveness, MBIs rarely reach POC. As such, innovative strategies such as self-directed app-based intervention may reduce the treatment gap. Considering the lack of research examining the effectiveness of MBIs among POC, especially those who experience elevated levels of race-related stress, this study will employ a randomized control trial (RCT) approach to examine whether receiving an app-based MBI engages the hypothesized mechanisms of change (i.e., mindfulness, self-compassion, experiential avoidance, rumination, emotion suppression) among POC. Similarly, the study will test whether the intervention leads to decreases in the negative mental health outcomes more often associated with exposure to race-related stress (i.e., stress, anxiety, depression). Acceptability, adherence, and satisfaction also will be analyzed to explore whether a non-culturally adapted MBI is still relevant for POC who face race-related stress. Results from this trial will contribute to the nascent data on MBI acceptability and effectiveness with POC. To the investigators' knowledge, this study will also be the first to include a sample of POC recruited based on elevated levels of race-related stress, a high-risk population that is not commonly targeted in MBI research.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
App-Based Mindfulness Meditation for People of Color Who Experience Race-Related Stress: Protocol for a Randomized Controlled Trial.
Ramos G, Aguilera A, Montoya A, Lau A, et al · · 2022 · cited 8× · PMID 35436228 · DOI 10.2196/35196 -
A Self-Guided App-Based Mindfulness Intervention for Racially and Ethnically Minoritized Individuals Who Experience Discrimination-Related Mental Health Symptoms: Randomized Controlled Trial.
Ramos G, Montoya AK, Aguilera A, Lau AS, et al · · 2026 · PMID 42133556 · DOI 10.2196/84328
Verify or expand the search:
- PubMed search for NCT05027113
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Mindfulness meditation
Trials testing the same drug.
- NCT07502547 — The Effect of a Mindfulness-Based Stress Reduction Program on Feelings of Being a Geriatric Burden in Older Women · NA · active not recruiting
- NCT07184983 — RS-tDCS for Cannabis Use Disorder: The C.A.R.E.S. Initiative · NA · recruiting
- NCT06717399 — Effect of Telehealth Mindfulness on Sleep and Anxiety in Acquired Brain Injury Population · NA · completed
- NCT06635278 — Mindfulness Meditation: Alleviating Symptoms and Inflammation in Nurses · NA · active not recruiting
- NCT06064994 — Impact Of Mindfulness Meditation On Pain, Quality Of Sleep, Self-Esteem · NA · completed
Other recruiting trials for Stress, Psychological
Currently open trials in the same condition.
- NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety · NA · recruiting
- NCT07255365 — Virtual Reality-Based 360° Clinic Walkthrough for Reducing Examination Anxiety in Preschool Children · NA · recruiting
- NCT07313735 — The Effect of Cartoon Character-Printed Band Use During Burn Dressing on Fear, Stress, Pain, and Physiological Parameter · NA · recruiting
- NCT06899308 — Health Surveillance at Constructor University Bremen (CUB) and Among HAW-Hamburg Employees · recruiting
- NCT06771167 — Building Community Resilience Program · NA · recruiting
Other University of California, Los Angeles trials
Trials by the same sponsor.
- NCT04846517 — rTMS for Aneroxia Nervosa in Youth · NA · not yet recruiting
- NCT06701760 — Sodium Lactate in Severe TBI · Phase 2 · not yet recruiting
- NCT04996667 — Effect of iNO in Patients With Submassive and Massive PE · Phase 2 · withdrawn
- NCT05067387 — Evaluation of Oral THC and CBD in Men and Women · Phase 1 · not yet recruiting
- NCT07534696 — Evaluation of Non-Invasive Pelvic Floor Neuromuscular Stimulation for Urinary Incontinence After Prostatectomy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05027113 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, Los Angeles
- Last refreshed: 25 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05027113.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing